P.T. Tran

Evaluating the Correlation between Genomic Classifier and Digital Pathology-Based Multi-Modal AI Biomarkers in Localized Prostate Cancer

Adeniyi Adedayo Olabumuyi, Olger Huamaní Jordan, Jinhee Chang, C. Datnow-Martinez et autres

Hallmark Interferon-Alpha Response Analysis in Localized Prostate Cancer: Analysis of the NRG Oncology/RTOG 9202, 9413, 9902, 0126, and 0521 Clinical Trials

Adam C. Olson, Haixia Wang, William A. Hall, P.T. Tran et autres

us, ca (code pays fourni par la source)

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

A. Dal Pra, Pirus Ghadjar, Hyunnam Ryu, J.A. Proudfoot et autres

BACKGROUND: The SAKK 09/10 trial randomized biochemically recurrent prostate cancer patients to salvage radiation 64 Gy versus 70 Gy, and the NRG/RTOG 0126 randomized intermediate-risk prostate cancer patients to definitive radiation 70.2 Gy versus 79.2 Gy. We investigated a previously developed Post-Operative …

us, de, ch, ca (code pays fourni par la source)

Demographic Differences Between Consenting versus Non-Consenting Participants for Biospecimen Collection on NRG Prostate Cancer Trials

S.C. Kamran, Mariane Borges, Daniel E. Spratt, N. Vapiwala et autres

Examination of Decipher Prostate Genomic Classifier in Patients with De Novo Metastatic Disease from a Large Scale Real-World Clinical and Transcriptomic Data Linkage

Shalini Moningi, Jason Ho, J. Proudfoot, Philip Sutera et autres

us, ca (code pays fourni par la source)

Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus

S.K.B. Spohn, C. Draulans, A.U. Kishan, D. Spratt et autres

de (code pays fourni par la source)

Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer

N.R. Parikh, E.M. Chang, N.G. Nickols, M. Rettig et autres

us (code pays fourni par la source)